The impact of an integrated depression and HIV treatment program on mental health and HIV care outcomes among people newly initiating antiretroviral therapy in Malawi.

Journal: PloS one

Volume: 15

Issue: 5

Year of Publication: 2020

Affiliated Institutions:  Epidemiology Department, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, United States of America. NCDs & Mental Health Unit, Ministry of Health, Lilongwe, Malawi. Department of Mental Health, University of Malawi, College of Medicine, Blantyre, Malawi. University of North Carolina Project-Malawi, Tidziwe Centre, Lilongwe, Malawi. Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States of America. Friendship Bench Zimbabwe, Milton Park, Harare, Zimbabwe. United States Agency for International Development (USAID), Arlington, VA, United States of America.

Abstract summary 

Depression is highly prevalent among patients newly starting antiretroviral treatment (ART) in Malawi and many other countries. Untreated depression at ART initiation can disrupt the HIV care continuum. Effective approaches for depression screening and treatment exist for low-resource settings, but they are rarely applied. Identifying effective implementation strategies are critical.A pilot program integrated depression screening and treatment into routine HIV care using existing staff at two public health clinics in Malawi in two phases; a screening-only "control" phase and an active "intervention" phase. During the intervention phase, providers prescribed antidepressants or referred patients for Friendship Bench problem-solving therapy. We evaluated the program's impact on retention in HIV care, viral suppression, and depression remission at 6 months using tabular comparisons and log-binomial models to estimate adjusted risk ratios and mean differences among the intervention group relative to the control group.Nearly all consenting participants were screened for depression appropriately and 25% had mild to severe depressive symptoms. During the intervention phase, 86% of participants with mild depressive symptoms started Friendship Bench therapy and 96% of participants with moderate to severe depressive symptoms started antidepressants. Few participants in the intervention group received consistent depression treatment over their first 6 months in care. In the adjusted main analysis, program exposure did not demonstrably affect most HIV or mental health outcomes, though the probability of currently being on ART at 6 months was significantly lower among the intervention group than the control group [RR 0.6(95%CI: 0.4-0.9)].While it is feasible to integrate depression screening and treatment initiation into ART initiation, providing ongoing depression treatment over time is challenging. Similar implementation science studies focused on maintaining depression management will be increasingly important as we strive to understand and test the best ways to implement evidence-based depression treatment within HIV care.

Authors & Co-authors:  Stockton Melissa A MA Udedi Michael M Kulisewa Kazione K Hosseinipour Mina C MC Gaynes Bradley N BN Mphonda Steven M SM Maselko Joanna J Pettifor Audrey E AE Verhey Ruth R Chibanda Dixon D Lapidos-Salaiz Ilana I Pence Brian W BW

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Kim MH, Mazenga AC, Devandra A, Ahmed S, Kazembe PN, Yu X, et al. Prevalence of depression and validation of the Beck Depression Inventory-II and the Children's Depression Inventory-Short amongst HIV-positive adolescents in Malawi. Journal of the International AIDS Society. 2014;17(1).
Authors :  12
Identifiers
Doi : e0231872
SSN : 1932-6203
Study Population
Male,Female
Mesh Terms
Adult
Other Terms
Study Design
Study Approach
Country of Study
Publication Country
United States